Edwards Lifesciences Corporation logo
EWEdwards Lifesciences Corporation

Interest Coverage Ratio: 389.45x

popular:market cap|pe ratio|revenue|price history|total return

Is the interest coverage ratio high or low?

The interest coverage ratio of 389.45x is in line with its 5-year average of 389.16x, near the low end of its 5-year range (121.62x–1411.00x).

As of Sunday, June 28, 2026. 31.88% above its 12-month average of 295.31x.

Interest Expense|Total Debt|Debt/Equity|Operating Margin|All Metrics
Interest Coverage

EW Interest Coverage Ratio

389.45x

Reported quarterly interest coverage; no daily interpolation.

+371.90% 5Y
EW Interest Coverage Ratio

EW Average Interest Coverage Ratio Chart

EW Interest Coverage Ratio

EW Current vs Average Interest Coverage Ratio Chart

EW Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

389.45x

INTEREST COVERAGE RATIO AVG TTM

295.31x

INTEREST COVERAGE RATIO AVG 3Y

322.28x

INTEREST COVERAGE RATIO AVG 5Y

389.16x

INTEREST COVERAGE RATIO AVG 10Y

159.57x

INTEREST COVERAGE RATIO AVG 15Y

112.45x

INTEREST COVERAGE RATIO AVG 20Y

92.13x

CURRENT VS TTM AVG

+31.88%

CURRENT VS 3Y AVG

+20.84%

CURRENT VS 5Y AVG

+0.08%

CURRENT VS 10Y AVG

+144.07%

CURRENT VS 15Y AVG

+246.34%

CURRENT VS 20Y AVG

+322.70%

EW Competitors' Interest Coverage Ratio

NAMEMARKET CAPINTEREST COVERAGE RATIOTTM3Y5Y
Edwards Lifesciences Corporation (EW)$52.27B389.45x295.31x322.28x389.16x
Cencora, Inc. (COR)vs ›$55.67B8.69x10.46x10.41x11.51x
Cardinal Health, Inc. (CAH)vs ›$55.72B10.58x17.48x14.63x11.63x
Becton, Dickinson and Company (BDX)vs ›$56.49B4.21x4.38x4.79x4.28x
Humana Inc. (HUM)vs ›$46.08B2.30x2.38x5.10x7.90x
IDEXX Laboratories, Inc. (IDXX)vs ›$43.50B35.54x35.85x30.16x28.81x
Regeneron Pharmaceuticals, Inc. (REGN)vs ›$65.20B81.69x77.00x76.06x87.20x
Boston Scientific Corporation (BSX)vs ›$65.74B11.38x9.10x7.54x6.16x
Agilent Technologies, Inc. (A)vs ›$38.41B13.21x14.36x15.54x14.94x
Medline Inc. (MDLN)vs ›$32.87B2.72x2.21x1.60x1.60x

Financial Health Indicators

Interest Coverage

389.5x

Debt/Equity

0.07

Current Ratio

3.72

Formula: Interest Coverage = EBIT / Interest Expense

Reference ranges:

  • < 1.5x: EBIT is less than 1.5 times interest expense
  • 1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
  • 3x - 5x: EBIT is between 3 and 5 times interest expense
  • > 5x: EBIT is more than 5 times interest expense

Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.

Interest Coverage Ratio Formula & Definition

Interest Coverage = EBIT / Interest Expense

The interest coverage ratio measures operating earnings relative to interest expense.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Interest Coverage Ratio FAQ

What is the interest coverage ratio for Edwards Lifesciences Corporation (EW)?
The interest coverage ratio for EW stock is 389.45x.
Is Edwards Lifesciences Corporation's interest coverage ratio high or low?
The interest coverage ratio of 389.45x is in line with its 5-year average of 389.16x, near the low end of its 5-year range (121.62x–1411.00x).
What is the TTM average interest coverage ratio for Edwards Lifesciences Corporation (EW)?
The TTM average interest coverage ratio for EW stock is 295.31x.
What is the 3Y average interest coverage ratio for Edwards Lifesciences Corporation (EW)?
The 3Y average interest coverage ratio for EW stock is 322.28x.
What is the 5Y average interest coverage ratio for Edwards Lifesciences Corporation (EW)?
The 5Y average interest coverage ratio for EW stock is 389.16x.
What is the 10Y average interest coverage ratio for Edwards Lifesciences Corporation (EW)?
The 10Y average interest coverage ratio for EW stock is 159.57x.
What is the 15Y average interest coverage ratio for Edwards Lifesciences Corporation (EW)?
The 15Y average interest coverage ratio for EW stock is 112.45x.
What is the 20Y average interest coverage ratio for Edwards Lifesciences Corporation (EW)?
The 20Y average interest coverage ratio for EW stock is 92.13x.

EW Interest Coverage Ratio History

DATEINTEREST COVERAGE RATIO
2022-06-30389.45x
2022-03-31435.70x
2021-12-31301.50x
2021-09-30169.67x
2021-06-30180.24x
2021-03-31300.62x
2020-12-31362.30x
2020-09-30438.75x
2018-09-30121.62x
2018-06-301411.00x
2017-06-30169.87x
2017-03-31123.04x
2016-12-3124.29x
2016-06-3075.25x
2016-03-3184.13x
2015-12-3167.19x
2015-09-3062.32x
2015-06-3081.56x
2015-03-3168.92x
2014-12-3182.53x
2014-09-3051.80x
2014-06-3038.48x
2014-03-3126.71x
2013-12-3130.35x
2013-09-30101.30x
2013-06-30305.75x
2012-12-31109.92x
2012-09-30105.11x
2012-03-3178.27x
2011-12-3196.11x
2011-09-3059.90x
2011-06-30107.57x
2011-03-31156.80x
2010-12-31161.20x
2010-09-3096.29x
2010-06-30147.20x
2010-03-31313.50x
2009-12-31128.80x
2009-09-3062.67x
2009-06-30312.50x
2009-03-3168.38x
2008-06-30131.75x
2008-03-3186.75x
2007-09-3091.50x
2007-06-30117.75x
2007-03-31223.00x
2006-09-3050.25x
2006-06-3076.17x
2006-03-3173.33x
2005-12-314.87x
2005-09-3018.23x
2005-06-3013.94x
2005-03-3115.21x
2004-12-312.80x
2004-09-3010.38x
2004-06-3011.25x
2004-03-316.32x
2003-12-312.96x
2003-09-309.11x
2003-06-308.89x
2003-03-3112.22x
2002-12-312.70x
2002-09-30-15.15x
2002-06-3010.37x

Related Metrics

Interest ExpenseTotal DebtDebt/EquityOperating MarginAll Metrics

About Edwards Lifesciences Corporation

Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems. Additionally, they provide advanced surgical structural heart solutions, including the INSPIRIS aortic surgical valve, the KONECT RESILIA pre-assembled aortic tissue valved conduit for complex valve, root, and ascending aorta replacements, and the HARPOON Beating Heart Mitral Valve Repair System for patients suffering from degenerative mitral regurgitation. In the realm of critical care, Edwards supplies advanced hemodynamic monitoring systems that assess patients' cardiac function and fluid status in both surgical and intensive care environments. This offering also features the Acumen Hypotension Prediction Index software, which provides early alerts to clinicians regarding potential dangerously low blood pressure. The company distributes its products to healthcare providers through a combination of its proprietary sales force and independent distributor networks. Founded in 1958, Edwards Lifesciences Corporation maintains its headquarters in Irvine, California.

Irvine, CA
15,800 employees
www.edwards.com
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Bernard J. Zovighian
View full financials